The present study was designed to mimic a normal population with overactive bladder. In fact, both treatment-naïve patients and those with previous experience of overactive bladder therapy were ...

Tolterodine is contraindicated in patients who are allergic to the drug, with urinary retention, functional or structural gastrointestinal problems that reduce motility, increased eye pressure ...

The efficacy of tolterodine was maintainedduring open-label follow-up for aslong as 12 months for both tolterodine IR 2mg twice daily 22,23 and tolterodine ER 4 mgonce daily. 24 Studies that ...

Tolterodine Medication Information. Discover comprehensive details about Tolterodine, including its pronunciation, uses, dosage instructions, indications, and guidelines on how and when to take it ...

Tolterodine tartrate 2mg, 4mg; ext-rel caps. Swallow whole. 4mg once daily; may decrease to 2mg once daily. Concomitant strong CYP3A4 inhibitors (eg, ketoconazole, clarithromycin, ritonavir), or ...

Patients in the tolterodine ER arm who requested a dose increase continued to receive the maximum approved dose of 4 mg, in the same double-blind, double-dummy regimen.

Tolterodine-associated memory impairment, without the presence of hallucinations, has been reported only once previously. 4 Amnesia may be more common, but in the absence of cognitive testing, it ...

Objective: To examine levels of persistence andcompliance as well as the economic impact ofextended-release tolterodine (tolterodine ER) versusimmediate-and extended-release oxybutynin ...

Tolterodine Tartrate Extended-Release Capsules are available in 2mg and 4mg dosage strengths. Related Content. For more information call (800) RX-MYLAN or visit ...

--ANI Pharmaceuticals, Inc. today announced the launch of Tolterodine Extended-Release Capsules, 2 mg and 4 mg. This is also the second of two drugs that was developed by Inventia Healthcare ...

A total of 1022 patients (818 females, 204 males) aged 21 to 93 years were randomised into the study. Patients were enrolled in North America (53%), Europe (42%) and Australia (5%). These ...